Windtree Therapeutics New (WINT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,058 | -45,215 | -37,315 | -20,965 | -19,175 |
| Depreciation Amortization | 2,766 | 1,241 | 1,150 | 1,234 | 1,549 |
| Accounts receivable | 67 | -67 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,083 | 267 | 55 | -574 | 391 |
| Other Working Capital | -1,982 | 456 | 524 | -816 | -1,840 |
| Other Operating Activity | 3,121 | 2,864 | 2,702 | -1,577 | -5,195 |
| Operating Cash Flow | $-41,169 | $-40,454 | $-32,884 | $-22,698 | $-24,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -780 | -608 | -636 | -106 | -101 |
| Investing Cash Flow | $-780 | $-608 | $-636 | $-106 | $-101 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 70,774 | 43,551 | 22,927 | 27,977 |
| Debt Issued | N/A | 30,000 | N/A | N/A | N/A |
| Debt Repayment | -80 | -75 | -75 | -145 | -9,136 |
| Common Stock Issued | 457 | 204 | 6,747 | N/A | N/A |
| Other Financing Activity | 0 | -450 | 0 | 0 | 0 |
| Financing Cash Flow | $377 | $100,453 | $50,223 | $22,782 | $18,841 |
| Beginning Cash Position | 86,283 | 26,892 | 10,189 | 10,211 | 15,741 |
| End Cash Position | 44,711 | 86,283 | 26,892 | 10,189 | 10,211 |
| Net Cash Flow | $-41,572 | $59,391 | $16,703 | $-22 | $-5,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,169 | -40,454 | -32,884 | -22,698 | -24,270 |
| Capital Expenditure | -780 | -608 | -636 | -106 | -101 |
| Free Cash Flow | -41,949 | -41,062 | -33,520 | -22,804 | -24,371 |